Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
REVENUES    
Neurometric Services $ 22,200 $ 24,700
OPERATING EXPENSES    
Cost of neurometric service revenues 3,700 1,200
Research 31,600 22,700
Product development 295,300 123,400
Sales and marketing 105,700 123,200
General and administrative 1,021,800 378,900
Total operating expenses 1,458,100 649,400
OPERATING LOSS (1,435,900) (624,700)
OTHER INCOME (EXPENSE)    
Interest expense, net (2,500) (700)
Financing expenses (499,500)
Loss on extinguishment of debt (2,337,400)
Gain on derivative liabilities 11,300
Total other income (expense) (2,500) (2,826,300)
LOSS BEFORE PROVISION FOR INCOME TAXES (1,438,400) (3,451,000)
Provision for income taxes 1,800 300
NET LOSS $ (1,440,200) $ (3,451,300)
BASIC AND DILUTED NET LOSS PER SHARE    
From operations (in dollars per share) $ (0.69) $ (6.74)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and Diluted (in shares) 2,101,061 512,087